Ascentage Pharma Group International (AAPG) Invested Capital (2022 - 2024)
Ascentage Pharma Group International (AAPG) has 2 years of Invested Capital data on record, last reported at $38.2 million in Q4 2024.
- For Q4 2024, Invested Capital rose 1111.63% year-over-year to $38.2 million; the TTM value through Dec 2024 reached $38.2 million, changed N/A, while the annual FY2024 figure was $38.2 million, 1088.85% up from the prior year.
- Invested Capital reached $38.2 million in Q4 2024 per AAPG's latest filing, up from $3.2 million in the prior quarter.
- Across five years, Invested Capital topped out at $38.2 million in Q4 2024 and bottomed at $3.2 million in Q4 2023.